Jeffrey W. Jacobs - Nov 8, 2021 Form 4 Insider Report for ARDELYX, INC. (ARDX)

Role
Chief Scientific Officer
Signature
/s/ Elizabeth Grammer, Attorney-in-Fact for Jeffrey W. Jacobs
Stock symbol
ARDX
Transactions as of
Nov 8, 2021
Transactions value $
-$2,556
Form type
4
Date filed
11/10/2021, 04:17 PM
Previous filing
Aug 24, 2021
Next filing
Nov 16, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ARDX Common Stock Sale -$2.56K -2.17K -1.64% $1.18 130K Nov 8, 2021 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 29, 2021.
F2 Reflects the adjusted total which includes the purchase of 2,166 shares under the Ardelyx Employee Stock Purchase Plan on February 28, 2021.
F3 Reflects the adjusted total which includes the purchase of 2,540 shares under the Ardelyx Employee Stock Purchase Plan on August 31, 2021.